Bradley L. Radoff - 03 Jan 2022 Form 3 Insider Report for ENZO BIOCHEM INC (ENZB)

Role
Director
Signature
Bradley L. Radoff
Issuer symbol
ENZB
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
3
Filing time
10 Jan 2022, 20:50:03 UTC
Previous filing
17 Nov 2021
Next filing
17 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENZ Common Stock 3,898,100 03 Jan 2022 Direct
holding ENZ Common Stock 400,000 03 Jan 2022 By The Radoff Family Foundation F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock are directly held by The Radoff Family Foundation (the "Radoff Foundation"). Mr. Radoff is a director of the Radoff Foundation and may be deemed to beneficially own the shares of Common Stock held by the Radoff Foundation. Mr. Radoff disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.